Glaucoma Drug Helps Women with Blinding Disorder Linked to Obesity
An inexpensive glaucoma drug, when added to a weight loss plan, can improve vision for women with a disorder called idiopathic intracranial hypertension (IIH), according to a study funded by the National Institute of Health. The trial was funded by NIH's National Eye Institute, and coordinated by the Neuro-Ophthalmology Research Disease Investigator Consortium (NORDIC). NORDIC is chaired by Mark Kupersmith, MD, Director of Neuro-Ophthalmology Services at the New York Eye and Ear Infirmary of Mount Sinai. The results were published in the Journal of the American Medical Association and will be presented on May 2 during the Clinical Trials plenary session of the American Academy of Neurology meeting in Philadelphia.
-Dr. Mark Kupersmith, Director, Neuro-Ophthalmology Services, New York Eye and Ear Infirmary of Mount Sinai